BENEFIT, the Kingdom’s innovator and leading company in Fintech and electronic financial transactions service, has announced ...
The initiative forms part of BENEFIT’s broader efforts to equip Bahraini talent with practical, industry-relevant ...
Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results